"We’ve had a busy and exciting March quarter marked by a series of major achievements. Ryoncil® revenues are now approaching US$100 million since last year’s launch, we have ...

Relative to routine stenting, drug-eluting balloon revascularization with as-needed stenting produced similarly low target ...

I was misdiagnosed four times while a tumour pushed my eye out of its socket. As a Black woman, I knew I’d have no choice but ...

In biotech, strong updates don't always push the share price higher. The post Good news, falling shares: What's dragging this ASX stock lower? appeared first on The Motley Fool Australia.

A 76-year-old woman, who had a history of treated hepatitis C virus infection, presented with rapidly progressive kidney failure and a stroke. Palpable purpura on the legs was noted. A diagnosis ...